Back
18
Day Range
$33.03
$34.11
52-Week Range
$28.66
$117.33
Volume
1,215,584
50D / 200D Avg
$37.45
/
$64.86
Prev Close
$33.63
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 36.1 | 0.4 |
| P/B | 5.6 | 2.9 |
| ROE % | 15.0 | 3.7 |
| Net Margin % | 13.1 | 3.9 |
| Rev Growth 5Y % | 20.1 | 10.0 |
| D/E | 0.0 | 0.2 |
Analyst Price Target
Hold
$68.40
+102.2%
Low: $30.00
High: $100.00
Forward P/E
94.1
Forward EPS
$0.36
EPS Growth (est.)
+0.0%
Est. Revenue
880 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$8.40
$7.62 – $9.46
|
2.6 B | 1 |
| FY2029 |
$6.13
$5.56 – $6.90
|
2.1 B | 1 |
| FY2028 |
$2.89
$2.15 – $4.09
|
1.5 B | 3 |
Key Takeaways
Revenue grew 20.10% annually over 5 years — strong growth
Earnings declined -28.68% over the past year
ROE of 15.01% — decent returns on equity
Debt/Equity of 0.01 — conservative balance sheet
Generating 141.79M in free cash flow
P/E of 36.10 — premium valuation
Growth
Revenue Growth (5Y)
20.10%
Revenue (1Y)12.79%
Earnings (1Y)-28.68%
FCF Growth (3Y)5.70%
Quality
Return on Equity
15.01%
ROIC5.14%
Net Margin13.09%
Op. Margin5.88%
Safety
Debt / Equity
0.01
Current Ratio2.92
Interest Coverage0.00
Valuation
P/E Ratio
36.10
P/B Ratio5.55
EV/EBITDA77.75
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 12.79% | Revenue Growth (3Y) | 25.64% |
| Earnings Growth (1Y) | -28.68% | Earnings Growth (3Y) | -3.10% |
| Revenue Growth (5Y) | 20.10% | Earnings Growth (5Y) | -2.99% |
| Profitability | |||
| Revenue (TTM) | 761.41M | Net Income (TTM) | 99.65M |
| ROE | 15.01% | ROA | 11.91% |
| Gross Margin | 98.30% | Operating Margin | 5.88% |
| Net Margin | 13.09% | Free Cash Flow (TTM) | 141.79M |
| ROIC | 5.14% | FCF Growth (3Y) | 5.70% |
| Safety | |||
| Debt / Equity | 0.01 | Current Ratio | 2.92 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 36.10 | P/B Ratio | 5.55 |
| P/S Ratio | 4.72 | PEG Ratio | -1.22 |
| EV/EBITDA | 77.75 | Dividend Yield | 0.00% |
| Market Cap | 3.60B | Enterprise Value | 3.48B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 761.41M | 675.04M | 482.38M | 401.86M | 365.98M |
| Net Income | 99.65M | 139.73M | 106.14M | 101.42M | 112.51M |
| EPS (Diluted) | 0.82 | 1.23 | 0.94 | 0.87 | 0.89 |
| Gross Profit | 748.43M | 664.16M | 475.89M | 396.47M | 360.70M |
| Operating Income | 44.80M | 136.95M | 107.28M | 112.63M | 124.48M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 836.65M | 840.55M | 621.52M | 583.43M | 423.76M |
| Total Liabilities | 188.85M | 160.96M | 114.81M | 81.59M | 47.95M |
| Shareholders' Equity | 647.81M | 679.59M | 506.71M | 501.84M | 375.81M |
| Total Debt | 6.11M | 6.94M | 151,000.0 | 1.14M | 526,000.0 |
| Cash & Equivalents | 120.50M | 127.67M | 135.55M | 66.33M | 77.62M |
| Current Assets | 485.46M | 471.60M | 458.64M | 499.25M | 266.46M |
| Current Liabilities | 166.09M | 140.77M | 104.51M | 72.49M | 47.54M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#1001 of 1052
Recent Activity
Entered
Cash Flow Compounder
Mar 24, 2026